Personal Information
- Gender:male
- TimeZone:Europe/Dublin
Profile Statistics
- Member Since:10 May 2009
- Viewed:173
- Bookmarked:0
About me
Specialist training in Diabetes & Endocrinology in some of the reputed centres like the Hammersmith, Oxford, Cambridge and various University hospitals in Manchester. Present job as Consultant physician in Diabetes & Endocrinology at Salford Royal NHS Trust (Hope Hospital) which is one of the best university teaching hospitals in the U.K. Visit for further details.<wbr/><br/>CLINICALEXPERIE<wbr/>NCE:<wbr/> <br/>DIABETES: <br/>• He is a team leader responsible for coordinating diabetic care undertaken by physicians, nurse specialists, dieticians and chiropodists. <br/> <br/>• He has attended many diabetic pregnancy, diabetic nephropathy, diabetic foot, diabetic retinopathy and adolescent clinics, apart from annual and review clinics for new and established diabetics. <br/><br/>• He can confidently manage acute diabetic emergencies such as DKA and HHS and have excellent skills to provide a good diabetic foot service. <br/><br/>ENDOCRINOL OGY:<br/>• Has excellent experience in managing various endocrine conditions having worked in some of the best endocrine centres like the Hammersmith, Addenbrooke’s&<wbr/>#8217;,<wbr/> Salford Royal, Manchester Royal and Christie’s. <br/><br/>• He is competent with screening and initial work-up of patients with pituitary disease before referral to neurosurgery or radiotherapy. and supervising and interpreting various other endocrine tests <br/> <br/>• He has attended the Royal College national certification course for administering radio iodine and the CALRAD training at Birmingham. Administered radio active iodine to various thyrotoxic patients. <br/><br/>• We<wbr/>ll<wbr/> versed with endocrine procedures including thyroid biopsies and ultrasound<wbr/><br/><wbr/><br/>• Did<wbr/>variety of tertiary clinics like Turner’s clinic, Congenital Adrenal Hyperplasia clinics, Growth hormone clinics, late effect clinics, MEN clinics, Adrenal carcinoma clinics, neuroendocrine clinics and radioiodine clinics. <br/><br/>• &#<wbr/>8226; Excellent<wbr/> experience in medical management of Obesity and pre and post op management of Bariatric patients,
Key skills
Specialist experience in management of Diabetes, Obesity and endocrine conditions.
Education
MBBS, Medicine
Jan 1994 - present (18 years, 7 months)
University of health sciences
MBBS , MRCP (UK), CCT, MRCP (Diabetes & Endocrinology)
Additional information
Honors & Awards:
Publications and Research:
1. Silent growth hormone secreting pituitary adenomas. IGF-1 is not sufficient to exclude growth hormone excess: 3 case reports
Kalavalapalli S1, Reid H2, Kane J3, Buckler H1, Trainer P4, Heald AH1 Ann Clin Biochem. 2007 Jan; 44 (Pt 1):89-93
2. Success ful discontinuation of insulin treatment after gestational diabetes is shown to be a case of MODY due to a glucokinase mutation
I Talapatra, S Kalavalapalli J Tymms Central European Journal of Medicine Volume 3, Number 2; June, 2008.
3. Isolated Hypoaldosteronism: An overlooked cause of Hyponatraemia
I Talapatra, S Kalavalapalli, J Tymms
Eur J Intern Med. 2007 May; 18(3):246-8
4. Diabetes associated with Atypical Antipsychotic Treatment may be Severe but Reversible
CRM Dibben, SS Kalavalapalli, SF Dinneen, PJ Mc Kenna
International Journal of Psychiatry in Medicine, vol 35, 2006
5. Rosiglitazon e, Metformin and Sulphonylureas as triple therapy in poorly controlled type 2 diabetes – Kalavalapalli S, Knight AH, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire.
6. S Kalavalapalli, I Talapatra & IPM O'Connell: A complex case of Multiple Endocrine Neoplasia type 1 with Metastatic Parathyroid Carcinoma. Central European Journal of Medicine (2010), 5(1): 53-58
Presentations:
5. A Case of XY Sex Reversal – oral presentation at British Endocrine Society, Manchester, Oct. 2008
Shyam Kalavalapalli, A.Heald, H.Buckler
Salford Royal Hospitals NHS Trust, Salford
6. An Audit of Radioiodine Treatment for Thyrotoxicosis in Cambridge (poster), British Endocrine Society, BES, Glasgow 1 April 2006) H Andreou S Kalavalapalli, VKK Chatterjee.
7. A confusing case of congenital adrenal hyperplasia (Oral Presentation Clinical Cases Meeting, Society of Endocrinology, London, Feb.2005)
K Kaushal, S Kalavalapalli FC Wu
8. Rosiglitazon e, Metformin and Sulphonylureas as triple therapy in poorly controlled type 2 diabetes – A prospective Study (Poster presentation at Diabetes UK)
1. Silent growth hormone secreting pituitary adenomas. IGF-1 is not sufficient to exclude growth hormone excess: 3 case reports
Kalavalapalli S1, Reid H2, Kane J3, Buckler H1, Trainer P4, Heald AH1 Ann Clin Biochem. 2007 Jan; 44 (Pt 1):89-93
2. Success ful discontinuation of insulin treatment after gestational diabetes is shown to be a case of MODY due to a glucokinase mutation
I Talapatra, S Kalavalapalli J Tymms Central European Journal of Medicine Volume 3, Number 2; June, 2008.
3. Isolated Hypoaldosteronism: An overlooked cause of Hyponatraemia
I Talapatra, S Kalavalapalli, J Tymms
Eur J Intern Med. 2007 May; 18(3):246-8
4. Diabetes associated with Atypical Antipsychotic Treatment may be Severe but Reversible
CRM Dibben, SS Kalavalapalli, SF Dinneen, PJ Mc Kenna
International Journal of Psychiatry in Medicine, vol 35, 2006
5. Rosiglitazon e, Metformin and Sulphonylureas as triple therapy in poorly controlled type 2 diabetes – Kalavalapalli S, Knight AH, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire.
6. S Kalavalapalli, I Talapatra & IPM O'Connell: A complex case of Multiple Endocrine Neoplasia type 1 with Metastatic Parathyroid Carcinoma. Central European Journal of Medicine (2010), 5(1): 53-58
Presentations:
5. A Case of XY Sex Reversal – oral presentation at British Endocrine Society, Manchester, Oct. 2008
Shyam Kalavalapalli, A.Heald, H.Buckler
Salford Royal Hospitals NHS Trust, Salford
6. An Audit of Radioiodine Treatment for Thyrotoxicosis in Cambridge (poster), British Endocrine Society, BES, Glasgow 1 April 2006) H Andreou S Kalavalapalli, VKK Chatterjee.
7. A confusing case of congenital adrenal hyperplasia (Oral Presentation Clinical Cases Meeting, Society of Endocrinology, London, Feb.2005)
K Kaushal, S Kalavalapalli FC Wu
8. Rosiglitazon e, Metformin and Sulphonylureas as triple therapy in poorly controlled type 2 diabetes – A prospective Study (Poster presentation at Diabetes UK)
